University of Kansas Cancer Center-Overland Park is a clinical research site located in Overland Park, Kansas, United States 66210.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Kansas Cancer Center-Overland Park has participated in 218 clinical trials with 167 currently active.
Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7.
Sponsors: National Cancer Institute (NCI), SWOG Cancer Research Network, ECOG-ACRIN Cancer Research Group.
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Kansas Cancer Center-Overland Park has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Kansas Cancer Center-Overland Park has 218 clinical trials on record, with 167 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7.
University of Kansas Cancer Center-Overland Park has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.